Literature DB >> 29637385

Blood Pressure Goals in Acute Stroke-How Low Do You Go?

Iryna Lobanova1, Adnan I Qureshi2.   

Abstract

PURPOSE OF REVIEW: Elevations in systolic blood pressure (BP) greater than 140 mmHg are reported in the majority (75%) of patients with acute ischemic stroke and in 80% of patients with acute intracerebral hemorrhages (ICH). This paper summarizes and updates the current knowledge regarding the proper management strategy for elevated BP in patients with acute stroke. Recent studies have generally showed a neutral effect of BP reduction on clinical outcomes among acute ischemic stroke patients. Thus, because of the lack of convincing evidence from clinical trials, aggressive BP reduction in patients presenting with acute ischemic stroke is currently not recommended. Although in patients treated with intravenous tissue plasminogen activator, guidelines are recommending BP < 180/105 mmHg but currently, the optimal BP management after reperfusion therapy still remains unclear. In acute ICH, the evidence from randomized clinical trials supports the immediate BP lowering targeting systolic BP to 140 mmHg, which is now recommended by guidelines.

Entities:  

Keywords:  Blood pressure; Intracerebral hemorrhage; Ischemic stroke

Mesh:

Substances:

Year:  2018        PMID: 29637385     DOI: 10.1007/s11906-018-0827-5

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  51 in total

1.  Effects of Early Hypertension Control after Ischaemic Stroke on the Outcome: A Meta-Analysis.

Authors:  Shuping Liu; Chengyan Li; Tao Li; Jing Xiong; Xueqing Zhao
Journal:  Cerebrovasc Dis       Date:  2015-10-22       Impact factor: 2.762

2.  Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Lewis B Morgenstern; J Claude Hemphill; Craig Anderson; Kyra Becker; Joseph P Broderick; E Sander Connolly; Steven M Greenberg; James N Huang; R Loch MacDonald; Steven R Messé; Pamela H Mitchell; Magdy Selim; Rafael J Tamargo
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

3.  Antihypertensive treatment prolongs tissue plasminogen activator door-to-treatment time: secondary analysis of the INSTINCT trial.

Authors:  Lesli E Skolarus; Phillip A Scott; James F Burke; Eric E Adelman; Shirley M Frederiksen; Allison M Kade; Jack D Kalbfleisch; Andria L Ford; William J Meurer
Journal:  Stroke       Date:  2012-10-02       Impact factor: 7.914

4.  Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.

Authors:  John F Potter; Thompson G Robinson; Gary A Ford; Amit Mistri; Martin James; Julia Chernova; Carol Jagger
Journal:  Lancet Neurol       Date:  2008-12-04       Impact factor: 44.182

5.  Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course.

Authors:  S Kazui; H Naritomi; H Yamamoto; T Sawada; T Yamaguchi
Journal:  Stroke       Date:  1996-10       Impact factor: 7.914

6.  Emergency department visits for ambulatory care sensitive conditions: insights into preventable hospitalizations.

Authors:  Ady Oster; Andrew B Bindman
Journal:  Med Care       Date:  2003-02       Impact factor: 2.983

7.  Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results.

Authors:  Cheryl Carcel; Xia Wang; Shoichiro Sato; Christian Stapf; Else Charlotte Sandset; Candice Delcourt; Hisatomi Arima; Thompson Robinson; Pablo Lavados; John Chalmers; Craig S Anderson
Journal:  Stroke       Date:  2016-05-03       Impact factor: 7.914

8.  Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.

Authors:  Craig S Anderson; Yining Huang; Ji Guang Wang; Hisatomi Arima; Bruce Neal; Bin Peng; Emma Heeley; Christian Skulina; Mark W Parsons; Jong Sung Kim; Qing Ling Tao; Yue Chun Li; Jian Dong Jiang; Li Wen Tai; Jin Li Zhang; En Xu; Yan Cheng; Stephane Heritier; Lewis B Morgenstern; John Chalmers
Journal:  Lancet Neurol       Date:  2008-04-07       Impact factor: 44.182

9.  A simple, assumption-free, and clinically interpretable approach for analysis of modified Rankin outcomes.

Authors:  George Howard; Jennifer L Waller; Jenifer H Voeks; Virginia J Howard; Edward C Jauch; Kennedy R Lees; Fenwick T Nichols; Volker W Rahlfs; David C Hess
Journal:  Stroke       Date:  2012-02-16       Impact factor: 7.914

10.  European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage.

Authors:  Thorsten Steiner; Rustam Al-Shahi Salman; Ronnie Beer; Hanne Christensen; Charlotte Cordonnier; Laszlo Csiba; Michael Forsting; Sagi Harnof; Catharina J M Klijn; Derk Krieger; A David Mendelow; Carlos Molina; Joan Montaner; Karsten Overgaard; Jesper Petersson; Risto O Roine; Erich Schmutzhard; Karsten Schwerdtfeger; Christian Stapf; Turgut Tatlisumak; Brenda M Thomas; Danilo Toni; Andreas Unterberg; Markus Wagner
Journal:  Int J Stroke       Date:  2014-08-24       Impact factor: 5.266

View more
  2 in total

Review 1.  Antihypertensive therapy in acute ischemic stroke: where do we stand?

Authors:  Eleni Georgianou; Panagiotis I Georgianos; Konstantinos Petidis; Vasilios G Athyros; Pantelis A Sarafidis; Asterios Karagiannis
Journal:  J Hum Hypertens       Date:  2018-09-19       Impact factor: 3.012

Review 2.  Hypertensive Crisis in Acute Cerebrovascular Diseases Presenting at the Emergency Department: A Narrative Review.

Authors:  Mariagiovanna Cantone; Giuseppe Lanza; Valentina Puglisi; Luisa Vinciguerra; Jaime Mandelli; Francesco Fisicaro; Manuela Pennisi; Rita Bella; Rosella Ciurleo; Alessia Bramanti
Journal:  Brain Sci       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.